. 2011 Oct;85(19):10117–10125. doi: 10.1128/JVI.05101-11

Table 1.

Influenza A viruses used in this study

Virus	Name in this study	Subtype	Pathogenicity^a	PB2 627^b	Patient symptoms^c
A/Netherlands/219/03	NL/219	H7N7	HPAI	K	Respiratory, fatal
A/Netherlands/230/03	NL/230	H7N7	HPAI	E	Conjunctivitis
A/Canada/504/04	Can/504	H7N3	HPAI	E	Conjunctivitis, respiratory
A/Canada/444/04	Can/444	H7N3	LPAI^d	E	Conjunctivitis, respiratory
A/New York/107/03	NY/107	H7N2	LPAI	E	Respiratory
A/Vietnam/1203/04	VN/1203	H5N1	HPAI	K	Respiratory, fatal
A/Thailand/16/04	Thai/16	H5N1	HPAI	K	Respiratory, fatal
A/Brisbane/59/07	Brisbane	H1N1	NA^e	E	Respiratory
A/Mexico/4482/09	Mex/4482	H1N1	NA	E	Respiratory

Pathogenicity phenotype using the Intravenous Pathogenicity Index (IVPI) (37).

Amino acid at position 627 in PB2.

As described previously (12, 21, 35, 48).

Can/504 and Can/444 differ by one amino acid in a 21-nucleotide insert at the HA cleavage site (24, 39).

NA, not applicable.